CN1245382C - 作为高选择性的环加氧酶-2抑制剂的4'-甲磺酰基联苯衍生物 - Google Patents
作为高选择性的环加氧酶-2抑制剂的4'-甲磺酰基联苯衍生物 Download PDFInfo
- Publication number
- CN1245382C CN1245382C CNB028200802A CN02820080A CN1245382C CN 1245382 C CN1245382 C CN 1245382C CN B028200802 A CNB028200802 A CN B028200802A CN 02820080 A CN02820080 A CN 02820080A CN 1245382 C CN1245382 C CN 1245382C
- Authority
- CN
- China
- Prior art keywords
- biphenyl
- methylsulfonyl
- acid
- compound
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C317/22—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
实施例 | COX-1 | COX-2 | ||||
浓度 | 30μM | 10μM | 3μM | 300nM | 100nM | 30nM |
SC-58635(标准物) | 81.3 | 66.5 | 64.3 | 73.0 | 59.9 | 51.2 |
1 | 64.7 | 50.5 | 44.4 | 59.7 | 50.7 | 46.2 |
2 | 77.1 | 70.5 | 61.5 | 76.5 | 60.5 | 55.2 |
3 | 23.4 | 10.1 | 9.4 | 10.1 | 5.5 | 5.0 |
4 | 78.4 | 70.4 | 58.2 | ~0 | ~0 | ~0 |
5 | 60.4 | 58.4 | 50.3 | 46.5 | 33.3 | 30.2 |
6 | 22.7 | 20.9 | 14.7 | ~0 | ~0 | ~0 |
7 | 41.1 | 40.5 | 36.8 | 68.4 | 60.3 | 47.6 |
8 | 49.7 | 40.2 | 29.7 | 54.7 | 42.7 | 27.4 |
9 | 70.8 | 66.4 | 49.8 | 70.4 | 59.8 | 44.2 |
Claims (3)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020010062491A KR100809489B1 (ko) | 2001-10-10 | 2001-10-10 | 사이클로옥시게나제-2의 저해제로서 선택성이 뛰어난4'-메탄설포닐-비페닐 유도체 |
KR62491/2001 | 2001-10-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1568309A CN1568309A (zh) | 2005-01-19 |
CN1245382C true CN1245382C (zh) | 2006-03-15 |
Family
ID=19715013
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB028200802A Expired - Fee Related CN1245382C (zh) | 2001-10-10 | 2002-10-02 | 作为高选择性的环加氧酶-2抑制剂的4'-甲磺酰基联苯衍生物 |
Country Status (9)
Country | Link |
---|---|
US (1) | US6583321B1 (zh) |
EP (1) | EP1434762B1 (zh) |
JP (1) | JP4026076B2 (zh) |
KR (1) | KR100809489B1 (zh) |
CN (1) | CN1245382C (zh) |
AT (1) | ATE348800T1 (zh) |
DE (1) | DE60216948T2 (zh) |
ES (1) | ES2278980T3 (zh) |
WO (1) | WO2003031398A1 (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040147581A1 (en) * | 2002-11-18 | 2004-07-29 | Pharmacia Corporation | Method of using a Cox-2 inhibitor and a 5-HT1A receptor modulator as a combination therapy |
US20040220155A1 (en) * | 2003-03-28 | 2004-11-04 | Pharmacia Corporation | Method of providing a steroid-sparing benefit with a cyclooxygenase-2 inhibitor and compositions therewith |
US20050014729A1 (en) * | 2003-07-16 | 2005-01-20 | Pharmacia Corporation | Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith |
US20050119262A1 (en) * | 2003-08-21 | 2005-06-02 | Pharmacia Corporation | Method for preventing or treating an optic neuropathy with a cox-2 inhibitor and an intraocular pressure reducing agent |
US20050107350A1 (en) * | 2003-08-22 | 2005-05-19 | Pharmacia Corporation | Method for the treatment or prevention of bone disorders with a cyclooxygenase-2 inhibitor alone and in combination with a bone disorder treatment agent and compositions therewith |
US20050187278A1 (en) * | 2003-08-28 | 2005-08-25 | Pharmacia Corporation | Treatment or prevention of vascular disorders with Cox-2 inhibitors in combination with cyclic AMP-specific phosphodiesterase inhibitors |
US20050113409A1 (en) * | 2003-09-03 | 2005-05-26 | Pharmacia Corporation | Method for the prevention or treatment of pain, inflammation and inflammation-related disorders with a Cox-2 selective inhibitor in combination with a nitric oxide-donating agent and compositions therewith |
US7790039B2 (en) * | 2003-11-24 | 2010-09-07 | Northwest Biotherapeutics, Inc. | Tangential flow filtration devices and methods for stem cell enrichment |
WO2006029436A1 (de) * | 2004-09-17 | 2006-03-23 | Universität Wien | Cox-ii-inhibitorverbindungen |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1063744A (en) * | 1964-05-25 | 1967-03-30 | American Cyanamid Co | 4-substituted-4'-tertiary aminoalkoxy biphenyls |
US3624142A (en) * | 1964-09-10 | 1971-11-30 | Merck & Co Inc | Substituted biphenyl acetic acid derivatives |
IE35838B1 (en) * | 1970-12-07 | 1976-06-09 | Reckitt & Colmann Prod Ltd | Pharmaceutical compositions |
BE793689A (fr) * | 1972-07-19 | 1973-05-02 | Renfag Sa | Procede de preparation d'acides 2-alcoxy-5-alcoysulfonylbenzoique |
JPS5735162B2 (zh) * | 1973-07-19 | 1982-07-27 | ||
AT336589B (de) * | 1974-05-20 | 1977-05-10 | Thomae Gmbh Dr K | Verfahren zur herstellung von neuen biphenylderivaten |
US5284978A (en) * | 1990-01-29 | 1994-02-08 | Yoshitomi Pharmaceutical Industries, Ltd. | Method for producing diphenyl sulfone compounds |
US5248828A (en) * | 1991-04-12 | 1993-09-28 | Sanko Kaihatsu Kagaku Kenkyusho | Method for preparing sulfones |
WO1995027692A1 (en) * | 1994-04-08 | 1995-10-19 | Smithkline Beecham Corporation | Subtituted biphenyl tnf inhibitors |
US5593994A (en) * | 1994-09-29 | 1997-01-14 | The Dupont Merck Pharmaceutical Company | Prostaglandin synthase inhibitors |
US5739166A (en) * | 1994-11-29 | 1998-04-14 | G.D. Searle & Co. | Substituted terphenyl compounds for the treatment of inflammation |
JPH10316650A (ja) * | 1997-05-13 | 1998-12-02 | Dev Center For Biotechnol | 新規な抗アテローム性動脈硬化薬 |
-
2001
- 2001-10-10 KR KR1020010062491A patent/KR100809489B1/ko not_active IP Right Cessation
-
2002
- 2002-10-02 WO PCT/KR2002/001844 patent/WO2003031398A1/en active IP Right Grant
- 2002-10-02 AT AT02781903T patent/ATE348800T1/de not_active IP Right Cessation
- 2002-10-02 EP EP02781903A patent/EP1434762B1/en not_active Expired - Lifetime
- 2002-10-02 ES ES02781903T patent/ES2278980T3/es not_active Expired - Lifetime
- 2002-10-02 JP JP2003534382A patent/JP4026076B2/ja not_active Expired - Fee Related
- 2002-10-02 CN CNB028200802A patent/CN1245382C/zh not_active Expired - Fee Related
- 2002-10-02 DE DE60216948T patent/DE60216948T2/de not_active Expired - Lifetime
- 2002-10-03 US US10/264,113 patent/US6583321B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US20030105095A1 (en) | 2003-06-05 |
CN1568309A (zh) | 2005-01-19 |
JP2005504844A (ja) | 2005-02-17 |
JP4026076B2 (ja) | 2007-12-26 |
EP1434762A4 (en) | 2006-01-04 |
DE60216948T2 (de) | 2007-08-30 |
DE60216948D1 (en) | 2007-02-01 |
KR100809489B1 (ko) | 2008-03-03 |
WO2003031398A1 (en) | 2003-04-17 |
ATE348800T1 (de) | 2007-01-15 |
EP1434762A1 (en) | 2004-07-07 |
EP1434762B1 (en) | 2006-12-20 |
ES2278980T3 (es) | 2007-08-16 |
KR20030030381A (ko) | 2003-04-18 |
US6583321B1 (en) | 2003-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1290832C (zh) | 作为高选择性的环加氧酶-2抑制剂的1h-吲哚衍生物 | |
CN1829728A (zh) | 新颖化合物 | |
CN1245382C (zh) | 作为高选择性的环加氧酶-2抑制剂的4'-甲磺酰基联苯衍生物 | |
CA2901650C (en) | Therapeutic agent for dyslipidemia | |
CN1301260A (zh) | 烟曲霉醇衍生物及其制备方法 | |
CN1934077A (zh) | 2-苯基丙酸衍生物及含有它们的药物组合物 | |
CN1422849A (zh) | 吲唑衍生物 | |
CN101058549A (zh) | 4-甲氧基-1,3-苯二取代酰胺衍生物 | |
CN1046505C (zh) | 1-苄基-3-羟甲基-吲唑与脂族2-羟基酸的醚的制法 | |
CN1142227A (zh) | 新的噻唑烷-4-酮衍生物 | |
CN1835743A (zh) | 用于治疗代谢紊乱的化合物 | |
CN101029046A (zh) | 取代的异穿心莲内酯衍生物、制备方法及其药物组合物 | |
CN1126737C (zh) | 新型吡咯化合物和其制备方法及含其的药物组合物 | |
CN101028260A (zh) | 取代的异穿心莲内酯衍生物的用途 | |
CN1019010B (zh) | 取代的β-二酮的制备方法 | |
CN1255387C (zh) | 可用作选择性cox-2抑制剂的嘧啶衍生物 | |
CN1022241C (zh) | 3-酰基-2-氧代吲哚-1-羧酰胺抗炎剂的前药化合物的制备 | |
CN1103533A (zh) | 用作抗转移药的具有生物活性的脲基衍生物 | |
CN1281601C (zh) | 作为高选择性环加氧酶-2抑制剂的联吡啶衍生物 | |
CN1239478C (zh) | 作为环加氧酶-2的高选择性抑制剂的3,4-二氢-1h-萘类衍生物 | |
CN1023896C (zh) | 羧基酰胺衍生物的制备方法 | |
CN1432013A (zh) | 咪唑衍生物或其盐以及含有该衍生物或其盐的药物 | |
CN1112113A (zh) | 新的三唑化合物及其制备方法和用途 | |
CN1649875A (zh) | 作为肿瘤坏死因子产生抑制剂的2-硫杂-二苯并薁及用于其制备的中间体 | |
CN1065454A (zh) | 旋光活性羧酸及其制法和药用组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: CJ CHEIL JEDANG CORP. Free format text: FORMER OWNER: CHEIL JEDANG CORP. Effective date: 20080912 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20080912 Address after: Seoul, South Kerean Patentee after: CJ Corp. Address before: Seoul Patentee before: First sugar refining Corporation |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060315 Termination date: 20151002 |
|
EXPY | Termination of patent right or utility model |